Risk Factors for COVID-19 and Respiratory Tract Infections During the Coronavirus Pandemic

Overview

Journal Vaccines (Basel)

Date 2024 Mar 28

PMID 38543963

Authors

Laurynas Mockeliunas

Rob C Van Wijk

Caryn M Upton

Jonathan Peter

Andreas H Diacon

Ulrika S H Simonsson

Affiliations

Soon will be listed here.

Abstract

(1) Background: Some individuals are more susceptible to developing respiratory tract infections (RTIs) or coronavirus disease (COVID-19) than others. The aim of this work was to identify risk factors for symptomatic RTIs including COVID-19 and symptomatic COVID-19 during the coronavirus pandemic by using infection incidence, participant baseline, and regional COVID-19 burden data. (2) Methods: Data from a prospective study of 1000 frontline healthcare workers randomized to Bacillus Calmette-Guérin vaccination or placebo, and followed for one year, was analyzed. Parametric time-to-event analysis was performed to identify the risk factors associated with (a) non-specific symptomatic respiratory tract infections including COVID-19 (RTIs+COVID-19) and (b) symptomatic RTIs confirmed as COVID-19 using a polymerase chain reaction or antigen test (COVID-19). (3) Results: Job description of doctor or nurse (median hazard ratio [HR] 1.541 and 95% confidence interval [CI] 1.299-1.822), the reported COVID-19 burden (median HR 1.361 and 95% CI 1.260-1.469 for 1.4 COVID-19 cases per 10,000 capita), or a BMI > 30 kg/m (median HR 1.238 and 95% CI 1.132-1.336 for BMI of 35.4 kg/m) increased the probability of RTIs+COVID-19, while positive SARS-CoV-2 serology at enrollment (median HR 0.583 and 95% CI 0.449-0.764) had the opposite effect. The reported COVID-19 burden (median HR 2.372 and 95% CI 2.116-2.662 for 1.4 COVID-19 cases per 10,000 capita) and a job description of doctor or nurse (median HR 1.679 and 95% CI 1.253-2.256) increased the probability of developing COVID-19, while smoking (median HR 0.428 and 95% CI 0.284-0.648) and positive SARS-CoV-2 serology at enrollment (median HR 0.076 and 95% CI 0.026-0.212) decreased it. (4) Conclusions: Nurses and doctors with obesity had the highest probability of developing RTIs including COVID-19. Non-smoking nurses and doctors had the highest probability of developing COVID-19 specifically. The reported COVID-19 burden increased the event probability, while positive SARS-CoV-2 IgG serology at enrollment decreased the probability of RTIs including COVID-19, and COVID-19 specifically.

References

Dosne A, Bergstrand M, Karlsson M . An automated sampling importance resampling procedure for estimating parameter uncertainty. J Pharmacokinet Pharmacodyn. 2017; 44(6):509-520. PMC: 5686280. DOI: 10.1007/s10928-017-9542-0. View

Karki S, Muscatello D, Banks E, MacIntyre C, McIntyre P, Liu B . Association between body mass index and laboratory-confirmed influenza in middle aged and older adults: a prospective cohort study. Int J Obes (Lond). 2018; 42(8):1480-1488. DOI: 10.1038/s41366-018-0029-x. View

Guerrisi C, Ecollan M, Souty C, Rossignol L, Turbelin C, Debin M . Factors associated with influenza-like-illness: a crowdsourced cohort study from 2012/13 to 2017/18. BMC Public Health. 2019; 19(1):879. PMC: 6610908. DOI: 10.1186/s12889-019-7174-6. View

Ruan Z, Qi J, Qian Z, Zhou M, Yang Y, Zhang S . Disease burden and attributable risk factors of respiratory infections in China from 1990 to 2019. Lancet Reg Health West Pac. 2021; 11:100153. PMC: 8315661. DOI: 10.1016/j.lanwpc.2021.100153. View

Tsigaris P, Teixeira da Silva J . Smoking Prevalence and COVID-19 in Europe. Nicotine Tob Res. 2020; 22(9):1646-1649. PMC: 7337760. DOI: 10.1093/ntr/ntaa121. View

Kisiel M, Zhou X, Bjornsson E, Holm M, Dahlman-Hoglund A, Wang J . The risk of respiratory tract infections and antibiotic use in a general population and among people with asthma. ERJ Open Res. 2021; 7(4). PMC: 8628194. DOI: 10.1183/23120541.00429-2021. View

Hall V, Foulkes S, Charlett A, Atti A, Monk E, Simmons R . SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN). Lancet. 2021; 397(10283):1459-1469. PMC: 8040523. DOI: 10.1016/S0140-6736(21)00675-9. View

Van Wijk R, Mockeliunas L, Upton C, Peter J, Diacon A, Simonsson U . Seasonal influence on respiratory tract infection severity including COVID-19 quantified through Markov Chain modeling. CPT Pharmacometrics Syst Pharmacol. 2023; 12(9):1250-1261. PMC: 10508522. DOI: 10.1002/psp4.13006. View

Atsumi E, Yara S, Higa F, Hirata T, Haranaga S, Tateyama M . Influence of human T lymphotropic virus type I infection on the etiology of community-acquired pneumonia. Intern Med. 2009; 48(12):959-65. DOI: 10.2169/internalmedicine.48.1918. View

10.

Maccioni L, Weber S, Elgizouli M, Stoehlker A, Geist I, Peter H . Obesity and risk of respiratory tract infections: results of an infection-diary based cohort study. BMC Public Health. 2018; 18(1):271. PMC: 5819164. DOI: 10.1186/s12889-018-5172-8. View

11.

Nie W, Zhang Y, Jee S, Jung K, Li B, Xiu Q . Obesity survival paradox in pneumonia: a meta-analysis. BMC Med. 2014; 12:61. PMC: 4021571. DOI: 10.1186/1741-7015-12-61. View

12.

Upton C, Van Wijk R, Mockeliunas L, Simonsson U, McHarry K, van den Hoogen G . Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled, phase 3 trial. EClinicalMedicine. 2022; 48:101414. PMC: 9098089. DOI: 10.1016/j.eclinm.2022.101414. View

13.

Van Wijk R, Mockeliunas L, van den Hoogen G, Upton C, Diacon A, Simonsson U . Reproducibility in pharmacometrics applied in a phase III trial of BCG-vaccination for COVID-19. Sci Rep. 2023; 13(1):16292. PMC: 10539503. DOI: 10.1038/s41598-023-43412-3. View

14.

Van Wijk R, Simonsson U . Finding the right hazard function for time-to-event modeling: A tutorial and Shiny application. CPT Pharmacometrics Syst Pharmacol. 2022; 11(8):991-1001. PMC: 9381898. DOI: 10.1002/psp4.12797. View

15.

Cohen S, Tyrrell D, Russell M, Jarvis M, Smith A . Smoking, alcohol consumption, and susceptibility to the common cold. Am J Public Health. 1993; 83(9):1277-83. PMC: 1694990. DOI: 10.2105/ajph.83.9.1277. View

16.

Tang H, Lai C, Chao C . Changing Epidemiology of Respiratory Tract Infection during COVID-19 Pandemic. Antibiotics (Basel). 2022; 11(3). PMC: 8944752. DOI: 10.3390/antibiotics11030315. View

17.

Williams C, Schweiger B, Diner G, Gerlach F, Haaman F, Krause G . Seasonal influenza risk in hospital healthcare workers is more strongly associated with household than occupational exposures: results from a prospective cohort study in Berlin, Germany, 2006/07. BMC Infect Dis. 2010; 10:8. PMC: 2836320. DOI: 10.1186/1471-2334-10-8. View

18.

Karanasos A, Aznaouridis K, Latsios G, Synetos A, Plitaria S, Tousoulis D . Impact of Smoking Status on Disease Severity and Mortality of Hospitalized Patients With COVID-19 Infection: A Systematic Review and Meta-analysis. Nicotine Tob Res. 2020; 22(9):1657-1659. PMC: 7337737. DOI: 10.1093/ntr/ntaa107. View

19.

Baik I, Curhan G, Rimm E, Bendich A, Willett W, Fawzi W . A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women. Arch Intern Med. 2000; 160(20):3082-8. DOI: 10.1001/archinte.160.20.3082. View

20.

Murphy V, Powell H, Wark P, Gibson P . A prospective study of respiratory viral infection in pregnant women with and without asthma. Chest. 2013; 144(2):420-427. PMC: 7107276. DOI: 10.1378/chest.12-1956. View